Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
CDC’s website is being modified to comply with President Trump’s Executive Orders.
Volume 5, Number 2—April 1999
Synopsis

Malaria Reemergence in the Peruvian Amazon Region

Javier Aramburú Guarda*, César Ramal Asayag*, and Richard Witzig†
Author affiliations: *Loreto Department of Public Health, Iquitos, Peru;; †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 7

Initial Plasmodium falciparum malaria treatment schemes in Loreto by district. Treatment efficiency* (cases cured/cohort number x 100) and efficacy** (cases cured/[cases cured + resistant cases] x 100) shown for each treatment scheme region. Treatment schemes: Primary-chloroquine; secondary-pyrimethamine-sulfadoxine; tertiary-quinine.

Figure 7. Initial Plasmodium falciparum malaria treatment schemes in Loreto by district. Treatment efficiency* (cases cured/cohort number x 100) and efficacy** (cases cured/[cases cured + resistant cases] x 100) shown for each treatment scheme region. Treatment schemes: Primary-chloroquine; secondary-pyrimethamine-sulfadoxine; tertiary-quinine.

Main Article

Page created: December 10, 2010
Page updated: December 10, 2010
Page reviewed: December 10, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external